Due to a high load of modelling projects, the rate of submission via the website has been reduced.
For a much higher submission rate, please use the Modelling API.

Multiple Assemblies exist for SMTL entry 5sy2
Structure-based design of a new series of N-piperidin-3-ylpyrimidine-5-carboxamides as renin inhibitors; X-RAY DIFFRACTION 2.25 Å

SMTL ID
5sy2.1
Ligands
2-acetamido-2-deoxy-beta-D-glucopyranose; N-ethyl-4-{[(furan-2-yl)methyl]amino}-2-methyl-N-[(3S)-piperidin-3-yl]pyrimidine-5-carboxamide; TRIETHYLENE GLYCOL; DIMETHYL SULFOXIDE
Polypeptides
Renin
Oligo-state
monomer
SMTL ID
5sy2.2
Ligands
2-acetamido-2-deoxy-beta-D-glucopyranose; N-ethyl-4-{[(furan-2-yl)methyl]amino}-2-methyl-N-[(3S)-piperidin-3-yl]pyrimidine-5-carboxamide; PENTAETHYLENE GLYCOL
Polypeptides
Renin
Oligo-state
monomer
SMTL ID
5sy2.3
Ligands
2-acetamido-2-deoxy-beta-D-glucopyranose; N-ethyl-4-{[(furan-2-yl)methyl]amino}-2-methyl-N-[(3S)-piperidin-3-yl]pyrimidine-5-carboxamide; TRIETHYLENE GLYCOL; DIMETHYL SULFOXIDE; PENTAETHYLENE GLYCOL
Polypeptides
Renin
Oligo-state
homo-hexamer